JH-EPICS Administrative Core
JH-EPICS 管理核心
基本信息
- 批准号:10688357
- 负责人:
- 金额:$ 44.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAntibody ResponseCOVID-19COVID-19 patientCOVID-19 treatmentCOVID-19 vaccineCollectionCommunicationCommunitiesDataDevelopmentEnsureEvaluationFosteringFundingGoalsImmune responseImmunityInformation DisseminationInternationalLeadershipMentorsMolecular TargetPathogenesisPeripheral Blood Mononuclear CellProceduresProfessional OrganizationsProgress ReportsPublicationsResearchResearch PersonnelResearch Project GrantsSamplingSerologySite VisitSpecimenT-LymphocyteUnited States National Institutes of HealthUniversitiesbiobankcellular targetingdata disseminationdata sharingmeetingsoutreachsevere COVID-19skillssocial mediavaccine-induced immunityweb site
项目摘要
JH-EPICS ADMINISTRATIVE CORE SUMMARY
The primary goal of the Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-
EPICS) is to systematically evaluate innate, T cell, and antibody responses to SARS-CoV-2 in peripheral blood
mononuclear cells and serological samples from COVID-19 patients. Through in depth analyses, the JH-
EPICS will identify the modifiers of the immune response and severe COVID-19 and isolate the cellular and
molecular targets for COVID-19 treatments as well as the correlates of protection necessary for SARS-CoV-2
vaccine-induced immunity. The primary objective of the JH-EPICS Administrative Core (AC) is to provide
centralized management, leadership, mentoring, sharing, and dissemination of the data from the proposed
Research Projects and Cores in JH-EPICS to ensure that the overarching research goals can be met. The first
Aim, under the Multiple PI leadership of Drs. Sabra Klein and Andrea Cox, will be to provide administrative and
budgetary management as well as scientific leadership and communication for JH-EPICS. The JH-EPICS AC
will distribute funds, organize monthly research meetings, and ensure integration of the JH-EPICS into the
COVID-19 research and educational networks at Johns Hopkins University. The AC will also develop standard
operating procedures for reviewing requests for specimens from the biorepository and their distribution as well
as the collection, processing, and sharing of data generated by the JH-EPICS and approved by the SeroNet
Steering Committee. The second Aim of the JH-EPICS AC will be to foster engagement with SeroNet and
other network activities. The JH-EPICS AC will participate in all trans-SeroNet initiatives, including
establishment of trans-SeroNet collaborative research projects. Finally, the third Aim of the JH-EPICS AC will
be to enhance dissemination of research findings from the JH-EPICS and establish an evaluation plan.
Dissemination of research findings from the JH-EPICS will involve publications and dissemination of results at
the annual SeroNet meeting, national and international meetings of professional societies, and the monthly
Center-wise research meetings. Development of a JH-EPICS website and social media presence will further
assist with dissemination of research findings to a broader audience. Finally, the JH-EPICS AC will establish a
rigorous evaluation plan, including annual progress reports, site visits, and requested documents (e.g., SOPs)
from NIH. The goal will be to ensure appropriate management and productive dissemination of research and
data from JH-EPICS to the broader community, including through public outreach.
JH-EPICS管理核心摘要
约翰霍普金斯SARS-CoV-2发病机制和免疫卓越中心(JH-
EPICS)是系统地评估外周血中对SARS-CoV-2的先天性、T细胞和抗体应答
来自COVID-19患者的单核细胞和血清样本。通过深入分析,
EPICS将识别免疫反应和严重COVID-19的调节剂,并分离细胞和
COVID-19治疗的分子靶点以及SARS-CoV-2所需保护的相关因素
疫苗诱导免疫JH-EPICS行政核心(AC)的主要目标是提供
集中管理、领导、指导、共享和传播来自拟议
JH-EPICS中的研究项目和核心,以确保能够实现总体研究目标。第一
在Sabra Klein博士和Andrea考克斯博士的领导下,多个PI的目标是提供行政和
预算管理以及JH-EPICS的科学领导和沟通。JH-EPICS AC
将分配资金,组织每月的研究会议,并确保将JH-EPICS整合到
约翰霍普金斯大学的COVID-19研究和教育网络。AC还将制定标准
审查生物储存库标本申请及其分发的操作程序
收集、处理和共享JH-EPICS生成并经SeroNet批准的数据
指导委员会。JH-EPICS AC的第二个目标是促进与SeroNet的合作,
其他网络活动。JH-EPICS AC将参与所有trans-SeroNet倡议,包括
建立跨SeroNet合作研究项目。最后,JH-EPICS AC的第三个目标将
加强JH-EPICS研究结果的传播,并制定评估计划。
JH-EPICS研究结果的传播将涉及出版物和结果的传播,
每年的SeroNet会议,专业协会的国家和国际会议,以及每月的
中心研究会议。JH-EPICS网站和社交媒体的开发将进一步
协助向更广泛的受众传播研究成果。最后,JH-EPICS AC将建立一个
严格的评估计划,包括年度进度报告、现场访问和要求的文件(例如,SOP)
来自NIH。目标是确保适当管理和富有成效地传播研究成果,
将JH-EPICS的数据提供给更广泛的社区,包括通过公共宣传。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SABRA L. KLEIN其他文献
SABRA L. KLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SABRA L. KLEIN', 18)}}的其他基金
2023 Sex Differences in Immunity Gordon Research Conference
2023 年免疫性别差异戈登研究会议
- 批准号:
10721480 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
项目 3:定义 SARS-CoV-2 感染后的抗体格局
- 批准号:
10221910 - 财政年份:2020
- 资助金额:
$ 44.47万 - 项目类别:
Project 3: Defining the antibody landscape after SARS-CoV-2 infection
项目 3:定义 SARS-CoV-2 感染后的抗体格局
- 批准号:
10688368 - 财政年份:2020
- 资助金额:
$ 44.47万 - 项目类别:
Sex and Age Differences in Immunity to Influenza (SADII)
流感免疫力的性别和年龄差异 (SADII)
- 批准号:
10213168 - 财政年份:2018
- 资助金额:
$ 44.47万 - 项目类别:
Genetic and hormonal mechanisms of sex differences in immune responses and influenza vaccine efficacy in young and aged mice
年轻和老年小鼠免疫反应和流感疫苗功效性别差异的遗传和激素机制
- 批准号:
10213173 - 财政年份:2018
- 资助金额:
$ 44.47万 - 项目类别:
Sex and Age Differences in Immunity to Influenza (SADII)
流感免疫力的性别和年龄差异 (SADII)
- 批准号:
10649070 - 财政年份:2018
- 资助金额:
$ 44.47万 - 项目类别:
Sex and Age Differences in Immunity to Influenza (SADII)
流感免疫力的性别和年龄差异 (SADII)
- 批准号:
10261763 - 财政年份:2018
- 资助金额:
$ 44.47万 - 项目类别:
相似海外基金
Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
描述 SARS-CoV-2 抗体反应及其与患者因素的关联:参与 GENCOV 研究的参与者的血清学分析
- 批准号:
495256 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
Understanding the human antibody response to a malaria transmission-blocking vaccine
了解人类抗体对疟疾传播阻断疫苗的反应
- 批准号:
MR/X009491/1 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
Research Grant
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
- 批准号:
10549646 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection
鉴定针对艰难梭菌感染的克隆抗体反应的抗原靶点
- 批准号:
10742376 - 财政年份:2023
- 资助金额:
$ 44.47万 - 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
- 批准号:
10688292 - 财政年份:2022
- 资助金额:
$ 44.47万 - 项目类别:
Molecular dissection of IgA antibody response by developing monoclonal IgA antibodies from nasal mucosa of mice
通过从小鼠鼻粘膜中开发单克隆 IgA 抗体对 IgA 抗体反应进行分子剖析
- 批准号:
22H02875 - 财政年份:2022
- 资助金额:
$ 44.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
- 批准号:
10634694 - 财政年份:2022
- 资助金额:
$ 44.47万 - 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
- 批准号:
10514498 - 财政年份:2022
- 资助金额:
$ 44.47万 - 项目类别:
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
- 批准号:
10527979 - 财政年份:2022
- 资助金额:
$ 44.47万 - 项目类别:
Factors related to antibody response of COVID-19 vaccines: with focusing on metabolomics
与 COVID-19 疫苗抗体反应相关的因素:重点关注代谢组学
- 批准号:
22H03334 - 财政年份:2022
- 资助金额:
$ 44.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




